Clinical Cancer Research Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003


PNOC003 is a multicenter precision medicine trial for children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG).


Previous
Previous

A Battle to Overcome Childhood Cancer: PNOC Helps a Family Through Hard Times

Next
Next

Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer